semaglutide patent expiry india India's to boost affordable access | Ms. Priyanka S. posted on the topic Patent Expiry Day: Novo Nordisk

Shang, Y., Siow, Y

In contrast, medical benefit drugs are typically subject to utilization management at the plan or provider level, often requiring prior authorization through medical policy review

10.1016/j.arr.2020.101037 50 GreiderC

If you're taking Ozempic, Wegovy, Mounjaro, or any other GLP-1 medication for weight loss, you're probably seeing results on the scale

GLP-1 drugs reduced kidney failure by 16% and major heart events by 13% across all studies.5 THE BOTTOM LINE GLP-1 medications are now considered a fourth pillar of kidney protection for people with type 2 diabetes, alongside blood pressure drugs, SGLT2 inhibitors, and finerenone

This gap widens further as treatment continues, with Retatrutide reaching 24.2% average weight loss by 48 weeks compared to Semaglutides 14.9%